Zacks Research Has Pessimistic Outlook of Plexus Q1 Earnings

Plexus Corp. (NASDAQ:PLXS) – Analysts at Zacks Research lowered their Q1 2026 earnings estimates for shares of Plexus in a note issued to investors on Wednesday, November 5th. Zacks Research analyst Team now anticipates that the technology company will post earnings per share of $1.52 for the quarter, down from their previous forecast of $1.56. The consensus estimate for Plexus’ current full-year earnings is $5.90 per share. Zacks Research also issued estimates for Plexus’ Q2 2026 earnings at $1.51 EPS, Q3 2026 earnings at $1.65 EPS, Q4 2026 earnings at $1.71 EPS, Q2 2027 earnings at $1.71 EPS, Q3 2027 earnings at $1.82 EPS, Q4 2027 earnings at $1.86 EPS and FY2027 earnings at $7.07 EPS.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings data on Wednesday, October 22nd. The technology company reported $2.14 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.30. The business had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.05 billion. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The firm’s revenue for the quarter was up .7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.85 earnings per share. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS.

PLXS has been the topic of a number of other research reports. Benchmark reaffirmed a “buy” rating and issued a $165.00 target price on shares of Plexus in a research report on Friday, October 24th. Needham & Company LLC boosted their price target on Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Wall Street Zen downgraded Plexus from a “strong-buy” rating to a “buy” rating in a report on Sunday, October 19th. Stifel Nicolaus set a $150.00 target price on shares of Plexus in a research note on Friday, October 24th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Plexus in a report on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $159.00.

Plexus Trading Down 0.2%

Shares of NASDAQ:PLXS opened at $143.26 on Monday. The company’s 50-day moving average price is $142.55 and its two-hundred day moving average price is $135.55. Plexus has a one year low of $103.43 and a one year high of $172.89. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.77. The stock has a market capitalization of $3.87 billion, a PE ratio of 22.88 and a beta of 0.80.

Institutional Trading of Plexus

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in Plexus by 0.6% in the 3rd quarter. Vanguard Group Inc. now owns 3,683,845 shares of the technology company’s stock valued at $533,016,000 after acquiring an additional 22,374 shares during the period. State Street Corp grew its position in shares of Plexus by 2.3% in the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after purchasing an additional 24,115 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in shares of Plexus by 0.6% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 975,612 shares of the technology company’s stock worth $125,005,000 after purchasing an additional 6,257 shares during the period. American Century Companies Inc. lifted its holdings in Plexus by 12.9% during the 2nd quarter. American Century Companies Inc. now owns 765,773 shares of the technology company’s stock worth $103,617,000 after purchasing an additional 87,551 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. boosted its stake in Plexus by 120.4% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company’s stock valued at $44,655,000 after purchasing an additional 190,360 shares during the period. Institutional investors own 94.45% of the company’s stock.

Insider Activity at Plexus

In related news, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the business’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $137.78, for a total transaction of $217,141.28. Following the transaction, the chief accounting officer directly owned 24,495 shares of the company’s stock, valued at approximately $3,374,921.10. The trade was a 6.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Patrick John Jermain sold 2,500 shares of the stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total value of $344,275.00. Following the completion of the sale, the chief financial officer owned 20,959 shares in the company, valued at approximately $2,886,263.89. This trade represents a 10.66% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 17,676 shares of company stock worth $2,450,935 in the last three months. 1.76% of the stock is owned by company insiders.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.